- Home
- FVAV vs CGC Comparison
FVAV vs CGC Comparison
Compare FVAV & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FVAV | CGC |
|---|---|---|
| Founded | 2025 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Pharmaceuticals and Biotechnology |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 366.8M | 389.2M |
| IPO Year | 2026 | 2023 |
Fundamental Metrics
Financial Performance| Metric | FVAV | CGC |
|---|---|---|
| Price | $10.14 | $0.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.1K | ★ 2.2M |
| Earning Date | N/A | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.17 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,759,000.00 |
| Revenue This Year | N/A | $21.39 |
| Revenue Next Year | N/A | $8.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.00 | $0.71 |
| 52 Week High | $10.35 | $2.38 |
Technical Indicators
Market Signals| Indicator | FVAV | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 42.58 | 25.02 |
| Support Level | $10.05 | N/A |
| Resistance Level | $10.20 | $1.08 |
| Average True Range (ATR) | 0.04 | 0.04 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 16.00 | 18.08 |
Price Performance
Historical ComparisonAbout FVAV Fortress Value Acquisition Corp. V Class A Ordinary Shares
Fortress Value Acquisition Corp V is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About CGC Canopy Growth Corporation
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.